R Fledrich


Affiliation: Max Planck Institute for Experimental Medicine
Country: Germany


  1. Fledrich R, Abdelaal T, Rasch L, Bansal V, Sch├╝tza V, Brugger B, et al. Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy. Nat Commun. 2018;9:3025 pubmed publisher
    ..We propose that lipid supplementation is an easily translatable potential therapeutic approach in CMT1A and possibly other dysmyelinating neuropathies. ..